Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amin Mazloom"'
Autor:
Graham McLennan, Amin Mazloom, Gregory A. Daniels, Daniel S. Grosu, Marcia Eisenberg, Razelle Kurzrock, Kimberly A. Holden, Shumei Kato, Prachi Nakashe, Kerry D. Fitzgerald, Eyad Almasri, Taylor J. Jensen, Christopher K. Ellison, Erin McCarthy, Lisa Kim, Aaron M. Goodman
Publikováno v:
Molecular Cancer Therapeutics. 20:2274-2279
When tissue biopsy is not medically prudent or tissue is insufficient for molecular testing, alternative methods are needed. Because cell-free DNA (cfDNA) has been shown to provide a representative surrogate for tumor tissue, we sought to evaluate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbb4571c5ecdc15463477fe226abb956
https://doi.org/10.1158/1535-7163.mct-20-1066
https://doi.org/10.1158/1535-7163.mct-20-1066
Autor:
Maged M. Costantine, Baha Sibai, Allan T. Bombard, Mark Sarno, Holly West, David M. Haas, Alan T. Tita, Michael J. Paidas, Erin A.S. Clark, Kim Boggess, Chad Grotegut, William Grobman, Emily J Su, Irina Burd, George Saade, Martin R. Chavez, Michael J. Paglia, Audrey Merriam, Carlos Torres, Mounira Habli, Georges Macones, Tony Wen, James Bofill, Anna Palatnik, Rodney K. Edwards, Sina Haeri, Pankaj Oberoi, Amin Mazloom, Matthew Cooper, Steven Lockton, Gary D. Hankins
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 79(7)
Background: The ability to diagnose preeclampsia clinically is suboptimal. Our objective was to validate a novel multianalyte assay and characterize its performance, when intended for use as an aid to rule-out preeclampsia. Methods: Prospective, mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6589a233b5f965101bdd43473123656
https://pubmed.ncbi.nlm.nih.gov/35545947
https://pubmed.ncbi.nlm.nih.gov/35545947
Autor:
Mathias Ehrich, Prachi Nakashe, Daniel S. Grosu, Razelle Kurzrock, Gregory A. Daniels, Christopher K. Ellison, Erin McCarthy, Amin Mazloom, Lisa Kim, Taylor J. Jensen, Shumei Kato, Graham McLennan, Aaron M. Goodman
Publikováno v:
Molecular Cancer Therapeutics. 18:448-458
Inhibitors of the PD-1/PD-L1/CTLA-4 immune checkpoint pathway have revolutionized cancer treatment. Indeed, some patients with advanced, refractory malignancies achieve durable responses; however, only a subset of patients benefit, necessitating new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6118be4da635aefbdc3213f1539e79
https://doi.org/10.1158/1535-7163.mct-18-0535
https://doi.org/10.1158/1535-7163.mct-18-0535
Autor:
Allan T. Bombard, Amin Mazloom, Gregory Hannum, Sung Kyun Kim, Andrew D. Hull, Chen Zhao, Paul Oeth, D. van den Boom, Timothy S. Burcham, Li Liu, John A. Tynan, Roger Chan Tim, Graham McLennan, Mathias Ehrich
Publikováno v:
Prenatal Diagnosis. 36:56-62
Objectives Clinical performance of a low coverage, low cost, massively parallel sequencing (MPS)-based assay to stratify risk of trisomy 21, 18, and 13 pregnancies was determined. Methods The study included 1100 samples with birth outcome or karyotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84ac2c892670c6eea12a7b4c3b82fcb1
https://doi.org/10.1002/pd.4712
https://doi.org/10.1002/pd.4712
Autor:
Amin Mazloom, Gregory A. Daniels, Christopher K. Ellison, Erin McCarthy, Graham McLennan, Mathias Ehrich, Prachi Nakashe, Daniel S. Grosu, Shumei Kato, Taylor J. Jensen, Razelle Kurzrock, Aaron M. Goodman, Lisa Tran
Publikováno v:
Cancer Research. 78:633-633
Inhibitors of the PD-1/PD-L1/CTLA4 immune checkpoint pathway have transformed the cancer treatment paradigm. It has been observed that even some patients with advanced, refractory malignancies achieve durable responses; however, only a minority of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aa3903dac61e7620942645a28afe189
https://doi.org/10.1158/1538-7445.am2018-633
https://doi.org/10.1158/1538-7445.am2018-633